Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Modest contribution of JAK2 V617F allele burden to the occurrence of major thrombosis in polycthemia vera and essential thrombocythemia.

Trifa AP, Bănescu C, Voina CM, Popa Ș, Török-Vistai T, Bojan AS, Dima D, Zdrenghea M, Fetica B, Vișan S, Tomuleasa C, Pârvu A, Urian L, Pop B, Popov VM, Andreescu M, Popp RA.

Blood Cells Mol Dis. 2018 Nov;73:45-46. doi: 10.1016/j.bcmd.2018.09.003. Epub 2018 Sep 20. No abstract available.

PMID:
30249383
2.

MECOM, HBS1L-MYB, THRB-RARB, JAK2, and TERT polymorphisms defining the genetic predisposition to myeloproliferative neoplasms: A study on 939 patients.

Trifa AP, Bănescu C, Bojan AS, Voina CM, Popa Ș, Vișan S, Ciubean AD, Tripon F, Dima D, Popov VM, Vesa ȘC, Andreescu M, Török-Vistai T, Mihăilă RG, Berbec N, Macarie I, Coliţă A, Iordache M, Cătană AC, Farcaș MF, Tomuleasa C, Vasile K, Truică C, Todincă A, Pop-Muntean L, Manolache R, Bumbea H, Vlădăreanu AM, Gaman M, Ciufu CM, Popp RA.

Am J Hematol. 2018 Jan;93(1):100-106. doi: 10.1002/ajh.24946. Epub 2017 Nov 10.

3.

Diffuse large B-cell lymphoma and polycythemia vera discovered at the onset - a rare association and its possible importance in lymphoma prognosis.

Popov VM, Dobrea CM, Popescu M, Pleşea IE, Grigorean VT, Sinescu RD, Strâmbu VD.

Rom J Morphol Embryol. 2016;57(1):313-8.

4.

c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines.

Gravina GL, Festuccia C, Popov VM, Di Rocco A, Colapietro A, Sanità P, Monache SD, Musio D, De Felice F, Di Cesare E, Tombolini V, Marampon F.

Radiat Res. 2016 Apr;185(4):411-22. doi: 10.1667/RR14237.1.

PMID:
27104757
5.

TERT rs2736100 A>C SNP and JAK2 46/1 haplotype significantly contribute to the occurrence of JAK2 V617F and CALR mutated myeloproliferative neoplasms - a multicentric study on 529 patients.

Trifa AP, Bănescu C, Tevet M, Bojan A, Dima D, Urian L, Török-Vistai T, Popov VM, Zdrenghea M, Petrov L, Vasilache A, Murat M, Georgescu D, Popescu M, Pătrinoiu O, Balea M, Costache R, Coleș E, Șaguna C, Berbec N, Vlădăreanu AM, Mihăilă RG, Bumbea H, Cucuianu A, Popp RA.

Br J Haematol. 2016 Jul;174(2):218-26. doi: 10.1111/bjh.14041. Epub 2016 Apr 7.

PMID:
27061303
6.

Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis.

Marampon F, Gravina GL, Festuccia C, Popov VM, Colapietro EA, Sanità P, Musio D, De Felice F, Lenzi A, Jannini EA, Di Cesare E, Tombolini V.

J Endocrinol Invest. 2016 Apr;39(4):411-22. doi: 10.1007/s40618-015-0381-9. Epub 2015 Sep 3.

PMID:
26335302
7.

Hemorrhagic risk due to platelet dysfunction in myelodysplastic patients, correlations with anemia severity and iron overload.

Popov VM, Vladareanu AM, Bumbea H, Kovacs E, Savopol T, Iordache MM, Moisescu MG.

Blood Coagul Fibrinolysis. 2015 Oct;26(7):743-9. doi: 10.1097/MBC.0000000000000287.

PMID:
25811447
8.

Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay.

Marampon F, Gravina GL, Zani BM, Popov VM, Fratticci A, Cerasani M, Di Genova D, Mancini M, Ciccarelli C, Ficorella C, Di Cesare E, Festuccia C.

Int J Oncol. 2014 Jun;44(6):2121-31. doi: 10.3892/ijo.2014.2358. Epub 2014 Mar 24.

PMID:
24676782
9.

Assessment of changes in membrane properties of platelets from patients with chronic myeloid leukaemia in different stages of the disease.

Popov VM, Vladareanu AM, Bumbea H, Kovacs E, Moisescu MG, Onisai M, Iordache MM, Savopol T.

Blood Coagul Fibrinolysis. 2014 Mar;25(2):142-50. doi: 10.1097/MBC.0b013e328365776f.

PMID:
24346354
10.

Intravesical instillations with polydeoxyribonucleotides reduce symptoms of radiation-induced cystitis in patients treated with radiotherapy for pelvic cancer: a pilot study.

Bonfili P, Franzese P, Marampon F, La Verghetta ME, Parente S, Cerasani M, Di Genova D, Mancini M, Vittorini F, Gravina GL, Ruggieri V, Di Staso M, Popov VM, Tombolini V, Di Cesare E.

Support Care Cancer. 2014 May;22(5):1155-9. doi: 10.1007/s00520-013-2051-9. Epub 2013 Dec 10.

PMID:
24322388
11.

Strategies for imaging androgen receptor signaling pathway in prostate cancer: implications for hormonal manipulation and radiation treatment.

Gravina GL, Festuccia C, Bonfili P, Di Staso M, Franzese P, Ruggieri V, Popov VM, Tombolini V, Masciocchi C, Carosa E, Lenzi A, Jannini EA, Di Cesare E.

Biomed Res Int. 2013;2013:460546. doi: 10.1155/2013/460546. Epub 2013 Oct 29. Review. Erratum in: Biomed Res Int. 2014;2014:437910. doi: 10.1155/2014/437910. Giovanni Luca, Gravina [corrected to Gravina, Giovanni L].

12.

Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines.

Marampon F, Gravina GL, Popov VM, Scarsella L, Festuccia C, La Verghetta ME, Parente S, Cerasani M, Bruera G, Ficorella C, Ricevuto E, Tombolini V, Di Cesare E, Zani BM.

Int J Oncol. 2014 Jan;44(1):285-94. doi: 10.3892/ijo.2013.2167. Epub 2013 Nov 5.

PMID:
24189697
13.

Increased expression of dachshund homolog 1 in ovarian cancer as a predictor for poor outcome.

Liang F, Lü Q, Sun S, Zhou J, Popov VM, Li S, Li W, Liu Y, Jiang J, Kong B.

Int J Gynecol Cancer. 2012 Mar;22(3):386-93. doi: 10.1097/IGC.0b013e31824311e6.

PMID:
22367319
14.

Hormonal therapy promotes hormone-resistant phenotype by increasing DNMT activity and expression in prostate cancer models.

Gravina GL, Marampon F, Piccolella M, Motta M, Ventura L, Pomante R, Popov VM, Zani BM, Pestell RG, Tombolini V, Jannini EA, Festuccia C.

Endocrinology. 2011 Dec;152(12):4550-61. doi: 10.1210/en.2011-1056. Epub 2011 Oct 11.

15.

The role of breast cancer stem cells in metastasis and therapeutic implications.

Velasco-Velázquez MA, Popov VM, Lisanti MP, Pestell RG.

Am J Pathol. 2011 Jul;179(1):2-11. doi: 10.1016/j.ajpath.2011.03.005. Epub 2011 Apr 28. Review.

16.

MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals.

Marampon F, Gravina GL, Di Rocco A, Bonfili P, Di Staso M, Fardella C, Polidoro L, Ciccarelli C, Festuccia C, Popov VM, Pestell RG, Tombolini V, Zani BM.

Mol Cancer Ther. 2011 Jan;10(1):159-68. doi: 10.1158/1535-7163.MCT-10-0631.

17.

Acetylation and nuclear receptor action.

Wang C, Tian L, Popov VM, Pestell RG.

J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):91-100. doi: 10.1016/j.jsbmb.2010.12.003. Epub 2010 Dec 15. Review.

18.

Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation.

Gravina GL, Festuccia C, Marampon F, Popov VM, Pestell RG, Zani BM, Tombolini V.

Mol Cancer. 2010 Nov 25;9:305. doi: 10.1186/1476-4598-9-305. Review.

19.

Transcription elongation regulator 1 is a co-integrator of the cell fate determination factor Dachshund homolog 1.

Zhou J, Liu Y, Zhang W, Popov VM, Wang M, Pattabiraman N, Suñé C, Cvekl A, Wu K, Jiang J, Wang C, Pestell RG.

J Biol Chem. 2010 Dec 17;285(51):40342-50. doi: 10.1074/jbc.M110.156141. Epub 2010 Oct 18.

20.

Attenuation of Forkhead signaling by the retinal determination factor DACH1.

Zhou J, Wang C, Wang Z, Dampier W, Wu K, Casimiro MC, Chepelev I, Popov VM, Quong A, Tozeren A, Zhao K, Lisanti MP, Pestell RG.

Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6864-9. doi: 10.1073/pnas.1002746107. Epub 2010 Mar 29.

21.

The Dachshund gene in development and hormone-responsive tumorigenesis.

Popov VM, Wu K, Zhou J, Powell MJ, Mardon G, Wang C, Pestell RG.

Trends Endocrinol Metab. 2010 Jan;21(1):41-9. doi: 10.1016/j.tem.2009.08.002. Epub 2009 Nov 5. Review.

22.

The cell fate determination factor DACH1 is expressed in estrogen receptor-alpha-positive breast cancer and represses estrogen receptor-alpha signaling.

Popov VM, Zhou J, Shirley LA, Quong J, Yeow WS, Wright JA, Wu K, Rui H, Vadlamudi RK, Jiang J, Kumar R, Wang C, Pestell RG.

Cancer Res. 2009 Jul 15;69(14):5752-60. doi: 10.1158/0008-5472.CAN-08-3992.

23.

Altered expression of DACH1 and cyclin D1 in endometrial cancer.

Nan F, Lü Q, Zhou J, Cheng L, Popov VM, Wei S, Kong B, Pestell RG, Lisanti MP, Jiang J, Wang C.

Cancer Biol Ther. 2009 Aug;8(16):1534-9. Epub 2009 Aug 8.

PMID:
19502783
24.

Nuclear factor-kappaB enhances ErbB2-induced mammary tumorigenesis and neoangiogenesis in vivo.

Liu M, Ju X, Willmarth NE, Casimiro MC, Ojeifo J, Sakamaki T, Katiyar S, Jiao X, Popov VM, Yu Z, Wu K, Joyce D, Wang C, Pestell RG.

Am J Pathol. 2009 May;174(5):1910-20. doi: 10.2353/ajpath.2009.080706. Epub 2009 Apr 6.

25.

Dachshund inhibits oncogene-induced breast cancer cellular migration and invasion through suppression of interleukin-8.

Wu K, Katiyar S, Li A, Liu M, Ju X, Popov VM, Jiao X, Lisanti MP, Casola A, Pestell RG.

Proc Natl Acad Sci U S A. 2008 May 13;105(19):6924-9. doi: 10.1073/pnas.0802085105. Epub 2008 May 8.

26.

Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB.

Marampon F, Casimiro MC, Fu M, Powell MJ, Popov VM, Lindsay J, Zani BM, Ciccarelli C, Watanabe G, Lee RJ, Pestell RG.

Mol Biol Cell. 2008 Jun;19(6):2566-78. doi: 10.1091/mbc.E06-12-1110. Epub 2008 Mar 26.

27.

Acetylation in nuclear receptor signaling and the role of sirtuins.

Wang C, Powell MJ, Popov VM, Pestell RG.

Mol Endocrinol. 2008 Mar;22(3):539-45. doi: 10.1210/me.2007-0379. Epub 2007 Dec 28. Review.

28.

Sirtuins, nuclear hormone receptor acetylation and transcriptional regulation.

Whittle JR, Powell MJ, Popov VM, Shirley LA, Wang C, Pestell RG.

Trends Endocrinol Metab. 2007 Nov;18(9):356-64. Epub 2007 Oct 26. Review.

PMID:
17964799
29.

The functional significance of nuclear receptor acetylation.

Popov VM, Wang C, Shirley LA, Rosenberg A, Li S, Nevalainen M, Fu M, Pestell RG.

Steroids. 2007 Feb;72(2):221-30. Epub 2007 Feb 7. Review.

30.

Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis.

Pelphrey PM, Popov VM, Joska TM, Beierlein JM, Bolstad ES, Fillingham YA, Wright DL, Anderson AC.

J Med Chem. 2007 Mar 8;50(5):940-50. Epub 2007 Feb 2.

PMID:
17269758
31.

Epigenetics and the estrogen receptor.

Leader JE, Wang C, Popov VM, Fu M, Pestell RG.

Ann N Y Acad Sci. 2006 Nov;1089:73-87. Review.

PMID:
17261756
32.
33.

Analysis of complexes of inhibitors with Cryptosporidium hominis DHFR leads to a new trimethoprim derivative.

Popov VM, Chan DC, Fillingham YA, Atom Yee W, Wright DL, Anderson AC.

Bioorg Med Chem Lett. 2006 Aug 15;16(16):4366-70. Epub 2006 Jun 5.

PMID:
16750361
34.

2-cyano-3,12-dioxooleana-1,9(11)-diene-28-oic acid disrupts microtubule polymerization: a possible mechanism contributing to apoptosis.

Couch RD, Ganem NJ, Zhou M, Popov VM, Honda T, Veenstra TD, Sporn MB, Anderson AC.

Mol Pharmacol. 2006 Apr;69(4):1158-65. Epub 2006 Jan 11.

PMID:
16407469
35.

Radiology in Serbia.

Harris RD, Stojanovic S, Stepanov S, Popov VM.

AJR Am J Roentgenol. 2005 Jan;184(1):11-3. No abstract available.

PMID:
15615942
36.

[Changes in the mineral metabolic indices of osteoarthrosis patients with the use of radon therapy and mud therapy].

Dicheva MA, Khyshiktuev BS, Anikina LV, Popov VM.

Vopr Kurortol Fizioter Lech Fiz Kult. 1998 May-Jun;(3):37-8. Russian.

PMID:
9771145
37.

[The nootropic correction of disorders in learning and memory processes induced by extreme exposures].

Iasnetsov VV, Krylova IN, Popov VM.

Eksp Klin Farmakol. 1996 May-Jun;59(3):20-3. Russian.

PMID:
8974577
38.

[Vestibular-protective and anti-amnesia properties of adrenocorticotropic hormone fragments and their analogs].

Iasnetsov VV, Popov VM, Kiseleva NM, Kamenskiĭ AA, Nezavibat'ko VN.

Biull Eksp Biol Med. 1995 Jun;119(6):634-6. Russian. No abstract available.

PMID:
8589392
39.

[Antimotion-sickness effect of nooglutil and its neuronal mechanism].

Iasentsov VV, Pravdivtsev VA, Popov VM, Voronina TP, Kiseleva NM, Kozlov SB.

Biull Eksp Biol Med. 1995 May;119(5):515-6. Russian. No abstract available.

PMID:
7579248
40.

[A neuropharmacological study of amnesia in animals induced by ultra high frequency electromagnetic irradiation].

Iasnetsov VV, Pal'tsev IuP, Popov VM, Levina AV.

Med Tr Prom Ekol. 1995;(7):40-2. Russian. No abstract available.

PMID:
7551702
41.

[The clinical significance of the immunological phenotype in non-Hodgkin's lymphomas].

Golenkov AK, Miterev GIu, Popov VM, Shakher AL.

Ter Arkh. 1995;67(7):30-2. Russian.

PMID:
7482301
42.

[Correction of disruptions in learning and memory, caused by the effect of superhigh frequency electromagnetic emissions, by nootropic drugs].

Iasnetsov VV, Popov VM, Pal'tsev IuP, Levina AV, Motin VG.

Biull Eksp Biol Med. 1994 Dec;118(12):606-8. Russian. No abstract available.

PMID:
7703455
43.

[Hemangiopericytoma of the maxillofacial region].

Kosiakov MN, Goncharenko LL, Isakov SA, Popov VM.

Sov Med. 1991;(9):81-4. Russian. No abstract available.

PMID:
1798936
44.

[Pathomorphosis of acute leukemia].

Popov VM.

Sov Med. 1991;(9):15-8. Russian.

PMID:
1724709
45.

[Characteristics of hematopoiesis in patients with the leukopenic syndrome].

Osechenskaia GV, Popov VM, Sevast'ianova MG, Kovaleva LG.

Gematol Transfuziol. 1989 May;34(5):28-33. Russian.

PMID:
2744387
46.

[Preleukemia].

Osechenskaia GV, Sevast'ianova MG, Popov VM.

Gematol Transfuziol. 1985 Jun;30(6):9-17. Russian. No abstract available.

PMID:
4018533
47.

[Clinico-morphologic and scintigraphic characteristics of bone marrow, liver and spleen in patients with a leukopenic syndrome].

Osechenskaia GV, Karpov AP, Sevast'ianova MG, Popov VM, Kovaleva LG.

Gematol Transfuziol. 1984 Oct;29(10):17-21. Russian. No abstract available.

PMID:
6510666
48.

[Morphological characteristics of the pathomorphosis of acute leukemias treated with rubomycin and carminomycin].

Popov VM, Vinogorova GF.

Probl Gematol Pereliv Krovi. 1980 Jul;25(7):9-13. Russian. No abstract available.

PMID:
6931366
49.

[Use of transfusions of an erythrocyte mass in treating anemia in liver cirrhosis patients].

Zherebtsov LA, Zamchiĭ AA, Popov VM, Rzhanovich AP.

Probl Gematol Pereliv Krovi. 1980 Jan;25(1):15-8. Russian. No abstract available.

PMID:
7367395
50.

[Hybrid computer system for automation of physiologic research].

Liman AD, Popov VM, Rodionov IuV.

Fiziol Zh SSSR Im I M Sechenova. 1978 Oct;64(10):1505-7. Russian. No abstract available.

PMID:
720685

Supplemental Content

Loading ...
Support Center